Healthy Skepticism Library item: 3483
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
MLAM letter follow up—Scanpharm
1987 Feb; 2
Abstract:
Scanpharm is discontinuing production of all products containing amidopyrine and is reviewing indications for phenylbutazone.
Keywords:
*news story/developing countries/amidopyrine/phenylbutazone/Scanpharm/company responses/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES